Therapeutic Nail Polishes: Marketing or Real Benefit? What Actually Works

The term “therapeutic nail polish” has long moved beyond pharmacy shelves and become part of the mainstream beauty market. However, in 2026, the industry clearly distinguishes between two categories: genuine medicinal products used to treat fungal nail infections and cosmetic products that merely improve the appearance of the nail. This distinction defines the boundary between marketing claims and actual efficacy.

When a Therapeutic Nail Polish Is Truly a Treatment

The clinically proven effectiveness of therapeutic nail polishes is primarily associated with the treatment of onychomycosis, a fungal infection of the nail.

In European practice, one of the best-known active ingredients is amorolfine 5%, which is used to treat mild forms of fungal infections. In the United States, the American Academy of Dermatology identifies ciclopirox lacquer, efinaconazole, and tavaborole as topical treatments for fungal nail infections.

It is important to understand that these are not beauty products, but medical treatments with specific indications, application protocols, and limitations.

Even these products do not provide immediate cosmetic results. Treatment may take several months, and its effectiveness depends directly on consistent use.

What Actually Works in the Formula

When it comes to treating fungal infections, effectiveness depends on the active ingredient rather than the marketing name.

Among the most widely used active ingredients are:

Amorolfine 5%

Ciclopirox 8%

Efinaconazole 10%

Tavaborole 5%

Their purpose is not to “strengthen the nail,” but to target the fungal pathogen itself.

The delivery system is also important. The U.S. market has gradually shifted from traditional nail lacquers to more fluid solutions, as penetration through the nail plate has become a critical factor in treatment efficacy.

Where Marketing Begins

The challenge is that the term “therapeutic nail polish” is often used to describe cosmetic products that have no therapeutic function.

These include:

Nail-strengthening coatings

Serums

Keratin-based products

Calcium-enriched products

Oils

Vitamin-based treatments

Such products may:

Improve the appearance of the nail

Reduce brittleness

Support overall nail condition

However, they do not treat fungal infections and cannot replace medical therapy.

This is where the main conflict between marketing and reality arises: the word “therapeutic” creates an expectation of treatment, while the product often performs only a cosmetic function.

What Is Happening in the European Market

The European market is applying increasingly strict controls to product claims and positioning.

If a product is not classified as a medicinal product, it cannot directly claim therapeutic effects without appropriate scientific evidence. As a result, brands are increasingly adopting more precise wording such as:

Supports

Protects

Improves appearance

Helps reduce brittleness

At the same time, demand for “healthy nails” continues to grow. However, this demand is expressed not through hype around therapeutic nail polishes, but through growing interest in:

Gentler formulations

Transparent ingredient lists

Proper diagnosis

The European market is increasingly distinguishing between medical treatment and cosmetic care.

What Really Matters

The modern market is gradually adopting a more realistic approach.

First, proper diagnosis is essential. Not every nail problem is caused by a fungal infection.

Second, treatment requires time and consistency. Genuine medical treatments do not work like quick cosmetic solutions.

Third, cosmetic care and medical treatment are two different product categories.

This is exactly what the market is trying to communicate more clearly in 2026:

A healthy-looking nail does not always mean treatment, and treatment does not always produce immediate visible results.